Respiratory Failure: Causes, Types, Symptoms, and Treatment

Respiratory failure is a serious clinical condition in which the respiratory system can no longer maintain adequate oxygenation, ventilation, or both. It may develop suddenly during an acute illness, progress gradually with chronic disease, or occur as an acute deterioration in someone with preexisting respiratory dysfunction.

Common causes include obstructive lung disease, pneumonia, pulmonary edema, acute respiratory distress syndrome, neuromuscular weakness, central nervous system depression, and severe airway obstruction.

Effective management requires recognizing the type of failure, identifying its cause, assessing gas exchange and respiratory muscle function, and providing appropriate respiratory support.

What Is Respiratory Failure?

Respiratory failure occurs when the lungs and respiratory system cannot adequately exchange oxygen and carbon dioxide to meet the body’s metabolic needs. The problem may involve insufficient oxygen entering the blood, inadequate carbon dioxide removal, or a combination of both abnormalities.

The respiratory system depends on several processes working together:

• Adequate respiratory drive
• Patent airways
• Effective respiratory muscle contraction
• Sufficient alveolar ventilation
• Appropriate ventilation-perfusion matching
• Normal pulmonary blood flow
• An intact alveolar-capillary membrane
• Adequate cardiovascular function

Failure of any of these components can contribute to respiratory failure. In an otherwise healthy patient breathing room air at sea level, respiratory failure is commonly associated with a PaO₂ below approximately 60 mm Hg, a PaCO₂ of 50 mm Hg or greater, or both.

However, these values should never be interpreted in isolation. The patient’s baseline condition, inspired oxygen concentration, pH, respiratory effort, mental status, and overall clinical presentation are equally important.

Respiratory failure can generally be divided into two major forms:

• Type I respiratory failure (primarily involving impaired oxygenation)
• Type II respiratory failure (primarily involving inadequate ventilation)

Note: Some patients exhibit both abnormalities simultaneously.

Type I Respiratory Failure

Type I respiratory failure is also known as hypoxemic respiratory failure. The primary abnormality is an inability to maintain adequate arterial oxygen levels.

Patients with hypoxemic respiratory failure generally have a low PaO₂, while PaCO₂ may initially be normal or decreased because the patient compensates by increasing ventilation. Hypercapnia may develop later if respiratory muscle fatigue or severe pulmonary dysfunction occurs.

Causes of Hypoxemia

Several mechanisms can produce hypoxemia:

• Ventilation-perfusion mismatch
• Intrapulmonary shunting
• Alveolar hypoventilation
• Diffusion impairment
• Low inspired oxygen concentration
• Abnormal anatomic shunting

Note: Understanding the mechanism is important because different causes respond differently to oxygen therapy and positive airway pressure.

Ventilation-Perfusion Mismatch

Ventilation-perfusion mismatch is one of the most common causes of hypoxemia. For efficient gas exchange, ventilation reaching the alveoli must be reasonably matched with pulmonary blood flow. A mismatch occurs when ventilation and perfusion become unevenly distributed.

A low ventilation-perfusion ratio occurs when blood continues to flow through lung regions that receive inadequate ventilation. Common causes include:

• COPD
• Asthma
• Airway obstruction
• Mucus plugging
• Pneumonia
• Pulmonary edema
• Atelectasis
• Inhalation injury

In these conditions, some lung units continue to receive blood flow but receive less ventilation than normal. Hypoxemia caused by ordinary ventilation-perfusion mismatch usually improves when supplemental oxygen is administered because oxygen can increase the alveolar oxygen concentration in partially ventilated lung regions.

A high ventilation-perfusion ratio occurs when alveoli receive ventilation but receive inadequate blood flow. Pulmonary embolism is a classic example. These lung regions contribute to physiologic deadspace because ventilation is present without sufficient perfusion for effective gas exchange.

Intrapulmonary Shunting

An intrapulmonary shunt is a more severe form of ventilation-perfusion abnormality. Blood passes through pulmonary capillaries adjacent to alveoli that receive little or no ventilation.

This may occur when alveoli are:

• Collapsed
• Filled with fluid
• Filled with inflammatory material
• Severely consolidated

Common causes include ARDS, severe pulmonary edema, extensive pneumonia, and significant atelectasis.

Because blood traveling through these regions does not come into contact with adequately ventilated alveoli, increasing FiO₂ may have a limited effect. The poorly oxygenated blood mixes with blood from healthier lung regions and lowers the final arterial oxygen content.

Positive airway pressure may be necessary to improve oxygenation. PEEP during mechanical ventilation or CPAP during spontaneous breathing can:

• Recruit collapsed alveoli
• Increase functional residual capacity
• Reduce shunting
• Improve ventilation-perfusion matching
• Increase arterial oxygenation

Note: Severe hypoxemia that persists despite high concentrations of supplemental oxygen should therefore raise concern for significant shunting.

Alveolar Hypoventilation and Hypoxemia

Hypoventilation can also produce hypoxemia. When alveolar ventilation decreases, less fresh gas reaches the alveoli. PaCO₂ rises because carbon dioxide elimination decreases, while alveolar oxygen levels fall.

Pure alveolar hypoventilation differs from many intrinsic pulmonary disorders because the alveolar-capillary membrane may remain normal. In such cases, the alveolar-arterial oxygen gradient may remain relatively normal.

Causes of alveolar hypoventilation include:

• Drug overdose
• Central nervous system depression
• Neuromuscular weakness
• Spinal cord injury
• Severe obesity
• Chest-wall abnormalities
• Respiratory muscle fatigue

Note: Patients with pure hypoventilation often respond well to supplemental oxygen, although ventilatory support may still be necessary to correct carbon dioxide retention.

Diffusion Impairment

Oxygen must cross the alveolar-capillary membrane before reaching pulmonary capillary blood.

Diffusion may be impaired when:

• The membrane becomes thickened
• Available surface area decreases
• Pulmonary capillary transit time becomes too short
• Inspired oxygen tension decreases

Conditions that can impair diffusion include pulmonary fibrosis, pulmonary edema, emphysema, and other disorders that alter the alveolar-capillary interface.

Diffusion impairment generally affects oxygen more readily than carbon dioxide because carbon dioxide diffuses across tissue much more efficiently.

Assessing Oxygenation Failure

Arterial blood gases provide direct information about oxygenation.

A PaO₂ below approximately 60 mm Hg is an important finding, but it must be interpreted in relation to FiO₂. A PaO₂ of 60 mm Hg on room air is significantly different from a PaO₂ of 60 mm Hg while the patient is receiving an FiO₂ of 0.80.

A patient who remains severely hypoxemic despite a high FiO₂ may have substantial shunting and may require PEEP, CPAP, recruitment strategies, or invasive ventilatory support.

P/F Ratio

The PaO₂/FiO₂ ratio, commonly called the P/F ratio, provides a convenient measure of oxygenation efficiency.

It is calculated as:

PaO₂ ÷ FiO₂

For example, if the PaO₂ is 80 mm Hg while the patient is receiving an FiO₂ of 0.40:

80 ÷ 0.40 = 200

A higher value generally indicates better oxygenation.

Approximate interpretations include:

• Above 300: relatively preserved oxygenation
• 200 to 300: mild impairment
• 100 to 200: moderate impairment
• Below 100: severe oxygenation impairment

Note: The P/F ratio is also used when evaluating patients for ARDS, although ARDS diagnosis requires additional clinical criteria.

Type II Respiratory Failure

Type II respiratory failure is also known as hypercapnic or ventilatory respiratory failure. The primary problem is insufficient alveolar ventilation, resulting in inadequate carbon dioxide elimination.

PaCO₂ rises when carbon dioxide production exceeds the amount removed through alveolar ventilation. Acute increases generally lower arterial pH and produce respiratory acidosis.

Type II respiratory failure is sometimes described as ventilatory pump or bellows failure because the apparatus responsible for moving air into and out of the lungs is unable to maintain adequate ventilation.

Causes of Hypercapnic Respiratory Failure

Hypercapnic failure may result from problems involving respiratory drive, neuromuscular function, airway resistance, chest-wall mechanics, or excessive respiratory workload.

Reduced Respiratory Drive

Central respiratory drive can be impaired by:

• Opioid overdose
• Sedative overdose
• Brainstem injury
• Cerebrovascular disease
• Head trauma
• Encephalitis
• Severe hypothyroidism
• Central hypoventilation disorders

These conditions may reduce respiratory rate, tidal volume, or both. When drug-induced respiratory depression is caused by a specific medication, reversal agents may be appropriate. Naloxone may be used for opioid toxicity, while flumazenil may be used selectively for benzodiazepine effects.

However, airway protection and ventilatory assistance remain essential when the patient cannot maintain adequate ventilation.

Neuromuscular Weakness

Respiratory failure may occur even when the lungs themselves are structurally normal. Diseases affecting the spinal cord, peripheral nerves, neuromuscular junction, or respiratory muscles may reduce the patient’s ability to generate an adequate tidal volume.

Examples include:

• Guillain-Barré syndrome
• Amyotrophic lateral sclerosis
• Myasthenia gravis
• Muscular dystrophy
• Spinal cord injury
• Phrenic nerve dysfunction
• Botulism
• Poliomyelitis

As respiratory muscle weakness progresses, vital capacity decreases and effective cough becomes more difficult. Bulbar weakness may also impair airway protection and increase the risk of aspiration.

Serial measurements of vital capacity and inspiratory muscle strength can help detect worsening respiratory muscle dysfunction before severe blood gas abnormalities occur.

Increased Work of Breathing

Respiratory failure frequently develops when the workload imposed on the respiratory muscles exceeds their ability to sustain ventilation.

Factors that increase work of breathing include:

• Airway obstruction
• Reduced lung compliance
• Reduced chest-wall compliance
• Increased physiologic deadspace
• High metabolic demand
• Severe hypoxemia
• Intrinsic PEEP
• Pulmonary edema
• Acute lung injury

The patient may initially compensate by increasing respiratory rate and respiratory effort. As fatigue develops, ventilation becomes increasingly inefficient.

A common pattern is rapid, shallow breathing. The respiratory rate rises while tidal volume decreases. This strategy initially reduces the amount of muscular excursion required with each breath but eventually increases deadspace ventilation and reduces effective alveolar ventilation.

Late findings may include:

• Declining respiratory rate
• Bradypnea
• Apnea
• Altered mental status
• Worsening hypercapnia
• Respiratory acidosis

Note: A sudden decrease in respiratory rate in a severely distressed patient should not automatically be interpreted as improvement. It may indicate exhaustion.

Airway Resistance and Respiratory Failure

Airway resistance determines how much pressure must be generated to move gas through the airways. Resistance rises sharply as airway diameter decreases.

Causes include:

• Bronchospasm
• Airway edema
• Retained secretions
• Foreign-body obstruction
• Endotracheal tube narrowing
• COPD
• Asthma
• Bronchiectasis

As resistance rises, the respiratory muscles must produce greater pressure to maintain airflow. In severe asthma or COPD, the patient may initially compensate by generating high inspiratory and expiratory pressures. Eventually, respiratory muscle fatigue may develop.

A patient with severe asthma who initially has a low PaCO₂ because of hyperventilation but later develops a normal or rising PaCO₂ should be assessed carefully. Rising PaCO₂ in severe asthma may indicate deteriorating ventilation rather than improvement.

Lung Compliance and Respiratory Failure

Compliance describes how easily the lungs expand in response to applied pressure. Low compliance means the lungs are stiff and require greater pressure to achieve a given tidal volume.

Conditions associated with reduced compliance include:

• ARDS
• Atelectasis
• Pulmonary edema
• Pneumonia
• Obesity
• Chest-wall restriction
• Pneumothorax

Patients with low compliance often adopt a rapid, shallow breathing pattern because taking smaller breaths requires less pressure. However, this pattern may increase deadspace ventilation and respiratory muscle workload.

Emphysema produces a different problem. Lung compliance may be abnormally high because elastic recoil is reduced. The lungs inflate easily but may empty poorly, causing air trapping and dynamic hyperinflation.

Deadspace Ventilation

Deadspace refers to ventilation that does not effectively participate in gas exchange.

Anatomic deadspace includes the conducting airways. Alveolar deadspace occurs when alveoli are ventilated but inadequately perfused. Physiologic deadspace includes both.

Conditions that increase alveolar deadspace include:

• Pulmonary embolism
• Low cardiac output
• Severe blood loss
• Pulmonary vascular obstruction
• Excessive alveolar pressure

When deadspace increases, a greater portion of each breath is wasted. The patient must increase minute ventilation just to maintain the same amount of effective alveolar ventilation. If the patient cannot sustain this increased demand, PaCO₂ begins to rise.

Note: A deadspace-to-tidal-volume ratio above approximately 0.60 to 0.70 suggests severe impairment.

Acute Respiratory Failure

Acute respiratory failure develops over minutes, hours, or days. Because the body has little time to compensate, abnormalities in oxygenation, ventilation, and pH may be pronounced.

Acute hypercapnic failure commonly produces significant acidemia because the kidneys have not had enough time to retain bicarbonate. In acute respiratory acidosis, pH decreases by approximately 0.08 for every 10 mm Hg increase in PaCO₂ above normal.

Common causes include:

• Severe asthma
• COPD exacerbation
• Pneumonia
• ARDS
• Pulmonary edema
• Drug overdose
• Neuromuscular crisis
• Airway obstruction
• Major trauma

Note: Prompt recognition is essential because acute failure can progress rapidly to cardiopulmonary arrest.

Chronic Respiratory Failure

Chronic respiratory failure develops over weeks, months, or years. COPD and obesity-hypoventilation syndrome are common causes.

When PaCO₂ remains elevated over time, the kidneys compensate by retaining bicarbonate. The increased bicarbonate buffers excess hydrogen ions and moves the pH closer to normal.

As a result, a patient with chronic compensated respiratory acidosis may have:

• Elevated PaCO₂
• Elevated bicarbonate
• Near-normal or mildly reduced pH

Note: In chronic respiratory acidosis, pH decreases by approximately 0.03 for every 10 mm Hg increase in PaCO₂. Chronic hypoxemia may also stimulate erythropoietin production, resulting in secondary polycythemia.

Acute-on-Chronic Respiratory Failure

Patients with chronic respiratory disease can experience an acute deterioration that produces acute-on-chronic respiratory failure.

Common triggers include:

• Bacterial infection
• Viral infection
• Pneumonia
• Heart failure
• Pulmonary embolism
• Pneumothorax
• Medication nonadherence
• Excessive oxygen administration in susceptible patients
• Sedative medications

For these patients, the most important comparison is often not with normal blood gas values, but with the patient’s usual baseline.

For example, a chronically hypercapnic COPD patient may normally have a PaCO₂ of 55 mm Hg with a compensated pH. If the PaCO₂ rises to 80 mm Hg and the pH falls substantially, the change may indicate acute ventilatory deterioration.

Signs and Symptoms of Respiratory Failure

Clinical findings vary according to the cause and whether the primary problem is oxygenation, ventilation, or both.

Early signs may include:

• Dyspnea
• Tachypnea
• Tachycardia
• Accessory muscle use
• Nasal flaring
• Retractions
• Anxiety
• Restlessness
• Increased work of breathing

As respiratory failure progresses, findings may include:

• Confusion
• Lethargy
• Cyanosis
• Paradoxical breathing
• Respiratory alternans
• Weak respiratory effort
• Bradypnea
• Apnea
• Cardiac dysrhythmias
• Hemodynamic instability

Note: Neurologic deterioration is particularly important. Severe hypoxemia and hypercapnia can impair cerebral function. A patient who becomes increasingly confused, drowsy, or unresponsive should be evaluated urgently.

Respiratory Muscle Assessment

Several measurements can help assess whether a patient has enough respiratory muscle reserve to maintain spontaneous ventilation.

Vital Capacity

Vital capacity evaluates the maximum volume of gas that can be exhaled after a maximal inspiration.

A vital capacity below approximately 10 to 15 mL/kg of predicted body weight is concerning for inadequate ventilatory reserve. This measurement is especially useful in neuromuscular disorders.

Maximal Inspiratory Pressure

Maximal inspiratory pressure, also known as negative inspiratory force, provides information about inspiratory muscle strength.

A value weaker than approximately -20 to -25 cm H₂O suggests significant inspiratory muscle weakness. Trend changes may be more useful than a single measurement.

Tidal Volume

A normal resting tidal volume is approximately 5 to 7 mL/kg of predicted body weight. A tidal volume below approximately 4 to 5 mL/kg may indicate inadequate spontaneous ventilation, especially when accompanied by tachypnea.

Rapid Shallow Breathing Index

The rapid shallow breathing index is calculated by dividing respiratory frequency by tidal volume in liters. A high value indicates rapid, shallow breathing and limited ventilatory reserve.

An RSBI above approximately 105 is traditionally associated with a reduced likelihood of successful unsupported breathing, although it should not be used as the sole criterion for clinical decisions.

Respiratory Failure in COPD

COPD can cause both oxygenation and ventilatory failure. Airflow obstruction, mucus production, airway collapse, ventilation-perfusion mismatch, air trapping, and increased work of breathing all contribute.

Some patients develop chronic hypercapnia and renal bicarbonate retention. During acute exacerbations, PaCO₂ may rise further and pH may fall.

Noninvasive ventilation is particularly useful in COPD exacerbations complicated by hypercapnic respiratory acidosis. Patients should also receive appropriate treatment for the underlying exacerbation, which may include bronchodilators, corticosteroids, oxygen therapy, and treatment of infection when indicated.

Oxygen is commonly titrated to an SpO₂ of approximately 88% to 92% in patients at risk for worsening hypercapnia, depending on the clinical situation.

Respiratory Failure in ARDS

ARDS is a severe form of acute hypoxemic respiratory failure associated with diffuse inflammatory lung injury. Alveolar flooding, collapse, reduced compliance, and intrapulmonary shunting produce profound oxygenation impairment.

Patients commonly develop:

• Severe hypoxemia
• Bilateral pulmonary opacities
• Reduced lung compliance
• Tachypnea
• Increased work of breathing

Mechanical ventilation often requires lung-protective strategies. Lower tidal volumes, commonly around 6 mL/kg of predicted body weight, are used to limit excessive alveolar stretch.

Plateau pressure is generally maintained at or below approximately 30 cm H₂O when possible. PEEP is used to help maintain alveolar recruitment and improve oxygenation.

Respiratory Failure in Infants and Children

Infants and children can deteriorate rapidly because they have less respiratory reserve than adults. Their airways are smaller, so relatively minor swelling or mucus accumulation can greatly increase resistance. Their chest walls are also more compliant, which can reduce effective ventilation during severe distress.

Signs of pediatric respiratory distress may include:

• Tachypnea
• Nasal flaring
• Retractions
• Grunting
• Head bobbing
• Accessory muscle use
• Paradoxical breathing

As compensation fails, children may develop decreasing respiratory effort, bradycardia, lethargy, poor muscle tone, apnea, and worsening gas exchange.

Some children with neuromuscular weakness may develop severe respiratory failure without dramatic retractions because they cannot generate enough muscular force to produce visible respiratory effort.

Noninvasive Ventilation

Noninvasive ventilation provides positive-pressure respiratory support without placement of an endotracheal tube. Common forms include CPAP and bilevel positive airway pressure.

NIV can:

• Increase tidal volume
• Reduce respiratory muscle workload
• Improve alveolar ventilation
• Increase functional residual capacity
• Recruit alveoli
• Reduce intrinsic PEEP
• Improve oxygenation
• Reduce cardiac preload and afterload in selected patients

One of the strongest indications for NIV is acute hypercapnic respiratory failure caused by COPD exacerbation.

Patients with a PaCO₂ above approximately 45 mm Hg and a pH below 7.35 may benefit when they are alert enough to protect the airway and are otherwise appropriate candidates.

NIV may also be useful in acute cardiogenic pulmonary edema. However, NIV should not delay intubation when the patient is deteriorating.

Invasive Mechanical Ventilation

Endotracheal intubation and invasive mechanical ventilation may be required when respiratory failure is severe or noninvasive support is inappropriate.

Indications may include:

• Apnea
• Severe refractory hypoxemia
• Progressive respiratory acidosis
• Severe respiratory muscle fatigue
• Inability to protect the airway
• Hemodynamic instability
• Severe altered mental status
• Failed noninvasive ventilation
• Progressive cardiopulmonary deterioration

Note: Mechanical ventilation supports gas exchange while reducing the work placed on respiratory muscles. Initial support often aims to provide most or all of the patient’s required minute ventilation while the underlying disorder is treated.

Goals of Mechanical Ventilation

Mechanical ventilation is used to:

• Improve alveolar ventilation
• Correct severe respiratory acidosis
• Improve arterial oxygenation
• Reduce work of breathing
• Rest fatigued respiratory muscles
• Maintain adequate lung volume
• Prevent or reverse atelectasis

Ventilator settings should be individualized according to the patient’s disease process and response. Tidal volume is generally based on predicted body weight rather than actual body weight.

In many patients without severe acute lung injury, tidal volumes of approximately 6 to 8 mL/kg predicted body weight may be appropriate. Lower tidal volumes are generally preferred in ARDS.

Treating Hypercapnic Failure

Treatment of hypercapnic respiratory failure focuses on restoring adequate alveolar ventilation. Minute ventilation can be increased by increasing respiratory rate, tidal volume, or both, depending on the clinical situation.

However, changes should be made carefully in patients with obstructive lung disease because excessively high respiratory rates can worsen air trapping and dynamic hyperinflation.

In acute respiratory acidosis, improving pH is an important goal. In chronic hypercapnia, rapid normalization of PaCO₂ may be undesirable.

A chronically hypercapnic patient may have substantial renal bicarbonate retention. Rapid reduction of PaCO₂ can leave the bicarbonate temporarily elevated, resulting in posthypercapnic metabolic alkalosis.

Potential complications include:

• Hypokalemia
• Cardiac dysrhythmias
• Neurologic changes
• Seizures

Note: Ventilation should therefore be adjusted according to the patient’s clinical status, pH, and chronic baseline rather than automatically attempting to normalize PaCO₂.

Treating Hypoxemic Failure

Hypoxemic respiratory failure is treated by improving oxygen delivery and correcting the underlying mechanism.

Interventions may include:

• Supplemental oxygen
• CPAP
• PEEP
• Noninvasive ventilation
• Invasive mechanical ventilation
• Alveolar recruitment strategies
• Treatment of pulmonary edema
• Antibiotics when infection is present
• Bronchodilators for airway obstruction
• Prone positioning in selected severe ARDS patients

Note: When shunting is the major problem, simply increasing FiO₂ may not be sufficient. PEEP can improve oxygenation by reopening collapsed lung units and keeping them open during expiration.

Weaning From Mechanical Ventilation

Mechanical ventilation should be reduced as the underlying cause of respiratory failure improves. Before attempting spontaneous breathing, the patient should generally demonstrate:

• Improvement in the cause of respiratory failure
• Acceptable oxygenation
• Hemodynamic stability
• Adequate spontaneous respiratory effort
• Reasonable acid-base status

Typical oxygenation criteria may include a P/F ratio of approximately 150 to 200 or greater, PEEP of about 5 to 8 cm H₂O or less, and FiO₂ of approximately 0.40 to 0.50 or less.

A spontaneous breathing trial can then determine whether the patient can tolerate reduced ventilatory assistance.

Signs of failure include:

• Severe tachypnea
• Increasing work of breathing
• Diaphoresis
• Anxiety
• Hypoxemia
• Hypercapnia
• Worsening acidosis
• Hemodynamic instability
• Altered mental status
• Thoracoabdominal paradox

Note: If the trial fails, adequate ventilatory support should be restored while the underlying cause is identified and corrected.

Complications of Respiratory Failure

Respiratory failure can affect nearly every organ system.

Possible complications include:

• Sepsis
• Multiple-organ dysfunction
• Pulmonary embolism
• Pneumonia
• Barotrauma
• Cardiac dysrhythmias
• Hypotension
• Acute kidney injury
• Gastrointestinal bleeding
• Malnutrition
• Fluid imbalance
• Delirium
• Psychological distress

Note: Some complications may arise from the underlying disease, while others may result from prolonged critical illness, invasive catheters, endotracheal tubes, immobility, or mechanical ventilation. Preventive care is therefore an important part of respiratory failure management.

Respiratory Failure Practice Questions

1. What is respiratory failure?
Respiratory failure is a condition in which the respiratory system cannot maintain adequate oxygenation, ventilation, or both.

2. What are the two major types of respiratory failure?
The two major types are Type I hypoxemic respiratory failure and Type II hypercapnic respiratory failure.

3. What primarily occurs in Type I respiratory failure?
Type I respiratory failure primarily involves inadequate oxygenation of the arterial blood.

4. What primarily occurs in Type II respiratory failure?
Type II respiratory failure primarily involves inadequate alveolar ventilation and carbon dioxide removal.

5. What PaO₂ value is commonly associated with respiratory failure in an otherwise healthy adult breathing room air?
A PaO₂ below approximately 60 mm Hg is commonly associated with respiratory failure.

6. What PaCO₂ value is commonly associated with respiratory failure?
A PaCO₂ of approximately 50 mm Hg or greater may indicate respiratory failure, especially when accompanied by acidemia.

7. What is the most common cause of hypoxemia in respiratory failure?
Ventilation-perfusion mismatch is the most common cause of hypoxemia.

8. What happens during a low ventilation-perfusion ratio?
Blood continues to perfuse lung regions that receive inadequate ventilation.

9. Does hypoxemia caused by ventilation-perfusion mismatch usually improve with supplemental oxygen?
Yes. Hypoxemia caused by ventilation-perfusion mismatch usually improves with supplemental oxygen.

10. What is an intrapulmonary shunt?
An intrapulmonary shunt occurs when blood passes through perfused lung regions that receive little or no effective ventilation.

11. Why may severe shunt-related hypoxemia respond poorly to supplemental oxygen?
Blood flowing through unventilated alveoli cannot adequately contact inspired oxygen, so increasing FiO₂ alone may have limited effect.

12. How can PEEP improve oxygenation in a patient with significant shunting?
PEEP can recruit collapsed alveoli, increase functional residual capacity, reduce shunting, and improve oxygenation.

13. What effect does alveolar hypoventilation have on PaCO₂?
Alveolar hypoventilation causes PaCO₂ to increase because carbon dioxide elimination is reduced.

14. What effect does alveolar hypoventilation have on alveolar oxygen levels?
Alveolar hypoventilation lowers alveolar oxygen levels and may contribute to hypoxemia.

15. What is diffusion impairment?
Diffusion impairment occurs when oxygen transfer across the alveolar-capillary membrane becomes limited.

16. What conditions can contribute to impaired oxygen diffusion?
Pulmonary edema, pulmonary fibrosis, emphysema, and other disorders affecting the alveolar-capillary membrane can impair oxygen diffusion.

17. What is the P/F ratio?
The P/F ratio is the PaO₂ divided by the FiO₂ and is used to assess the severity of oxygenation impairment.

18. What does a low P/F ratio indicate?
A low P/F ratio indicates impaired oxygenation, with progressively lower values reflecting more severe dysfunction.

19. What does a P/F ratio below 100 generally indicate?
A P/F ratio below 100 generally indicates severe oxygenation impairment and is associated with severe ARDS when other diagnostic criteria are present.

20. What is the main blood gas abnormality in acute hypercapnic respiratory failure?
The main abnormality is an elevated PaCO₂ accompanied by a decreased pH from acute respiratory acidosis.

21. What causes hypercapnic respiratory failure?
Hypercapnic respiratory failure occurs when alveolar ventilation is insufficient to eliminate the carbon dioxide produced by the body.

22. What are common causes of reduced respiratory drive?
Drug overdose, brainstem injury, cerebrovascular disease, head trauma, central hypoventilation disorders, and severe hypothyroidism can reduce respiratory drive.

23. Which neuromuscular disorders can cause respiratory failure?
Guillain-Barré syndrome, amyotrophic lateral sclerosis, myasthenia gravis, muscular dystrophy, spinal cord injury, and botulism can cause respiratory failure.

24. Why is rapid, shallow breathing concerning in respiratory failure?
Rapid, shallow breathing may indicate increasing respiratory muscle fatigue and reduced effective alveolar ventilation.

25. What can a falling respiratory rate indicate in a patient who was previously severely tachypneic?
A falling respiratory rate may indicate respiratory muscle exhaustion and impending ventilatory failure rather than improvement.

26. What is respiratory muscle fatigue?
Respiratory muscle fatigue occurs when the respiratory muscles can no longer sustain the workload required to maintain adequate ventilation.

27. What is respiratory muscle weakness?
Respiratory muscle weakness is a reduction in the force-generating capacity and endurance of the respiratory muscles even when they are rested.

28. What does tachypnea often indicate in a patient with respiratory failure?
Tachypnea often indicates increased work of breathing and an attempt to maintain ventilation despite respiratory stress.

29. What is respiratory alternans?
Respiratory alternans is a breathing pattern in which rib-cage and abdominal breathing alternate, often indicating respiratory muscle dysfunction.

30. What is the significance of bradypnea in progressive respiratory failure?
Bradypnea is a late and dangerous finding that may indicate severe fatigue, central depression, or impending apnea.

31. How does acute hypercapnia typically affect pH?
Acute hypercapnia lowers pH and produces respiratory acidosis.

32. How does the body compensate for chronic hypercapnia?
The kidneys retain bicarbonate over time to help buffer the excess acid caused by chronically elevated PaCO₂.

33. How much does pH typically fall for every 10 mm Hg increase in PaCO₂ during acute respiratory acidosis?
The pH typically falls by about 0.08 for every 10 mm Hg increase in PaCO₂ during acute respiratory acidosis.

34. How much does pH typically fall for every 10 mm Hg increase in PaCO₂ during chronic respiratory acidosis?
The pH typically falls by about 0.03 for every 10 mm Hg increase in PaCO₂ during chronic respiratory acidosis.

35. What is acute-on-chronic respiratory failure?
Acute-on-chronic respiratory failure is a sudden deterioration in a patient who already has chronic respiratory dysfunction.

36. What are common causes of acute-on-chronic respiratory failure?
Common causes include respiratory infection, heart failure, pulmonary embolism, pneumothorax, chest-wall dysfunction, and failure to follow prescribed treatment.

37. Why is a patient’s baseline important when evaluating chronic respiratory failure?
The patient’s baseline helps determine whether current blood gas values represent a significant acute deterioration or a chronic compensated state.

38. What is a normal adult tidal volume during spontaneous breathing?
A normal adult tidal volume is approximately 5 to 7 mL/kg of predicted body weight.

39. What spontaneous tidal volume may indicate inadequate ventilatory reserve?
A tidal volume below about 4 to 5 mL/kg of predicted body weight may indicate inadequate ventilatory reserve.

40. What respiratory rate is generally considered normal for an adult?
A normal adult respiratory rate is approximately 12 to 20 breaths per minute.

41. What respiratory rate may suggest severe ventilatory compromise?
A respiratory rate greater than about 30 to 35 breaths per minute may suggest severe ventilatory compromise.

42. What is the rapid shallow breathing index?
The rapid shallow breathing index is the respiratory frequency divided by the tidal volume expressed in liters.

43. What RSBI value is traditionally associated with a reduced likelihood of successful unsupported breathing?
An RSBI greater than approximately 105 is traditionally associated with a reduced likelihood of successful unsupported breathing.

44. What vital capacity may indicate inadequate ventilatory reserve?
A vital capacity below approximately 10 to 15 mL/kg of predicted body weight may indicate inadequate ventilatory reserve.

45. What maximal inspiratory pressure suggests significant inspiratory muscle weakness?
A maximal inspiratory pressure weaker than about -20 to -25 cm H₂O suggests significant inspiratory muscle weakness.

46. Why are serial respiratory muscle measurements useful in neuromuscular disease?
Serial measurements can identify progressive weakness before severe respiratory failure develops.

47. How can Guillain-Barré syndrome lead to respiratory failure?
Guillain-Barré syndrome can cause ascending neuromuscular weakness that progressively impairs respiratory muscle function.

48. How can myasthenia gravis cause respiratory failure?
Myasthenia gravis can produce severe fatigable respiratory muscle weakness that progresses to myasthenic crisis.

49. Why can bulbar weakness increase respiratory complications?
Bulbar weakness can impair swallowing, cough, and airway-protective reflexes, increasing the risk of aspiration and pneumonia.

50. What is obesity-hypoventilation syndrome?
Obesity-hypoventilation syndrome is a condition in which obesity contributes to chronic daytime hypoventilation, hypercapnia, and often hypoxemia.

51. How can severe COPD lead to ventilatory failure?
Severe COPD can increase airway resistance, air trapping, deadspace ventilation, and respiratory muscle workload until alveolar ventilation becomes inadequate.

52. Why can severe asthma progress to respiratory failure?
Severe asthma can cause intense bronchospasm, airway inflammation, mucus obstruction, air trapping, and respiratory muscle fatigue that eventually impair ventilation.

53. Why is a rising PaCO₂ concerning during a severe asthma attack?
A rising PaCO₂ may indicate that the patient is no longer able to maintain the high level of ventilation needed to compensate for severe airway obstruction.

54. What can markedly diminished breath sounds indicate in severe asthma?
Markedly diminished breath sounds can indicate critically reduced airflow and impending respiratory failure.

55. How does increased airway resistance affect the work of breathing?
Increased airway resistance forces the respiratory muscles to generate greater pressure to move air through narrowed airways.

56. How does decreased lung compliance contribute to respiratory failure?
Decreased lung compliance makes the lungs harder to expand, increasing the work of breathing and potentially causing respiratory muscle fatigue.

57. What breathing pattern commonly develops when lung compliance is reduced?
Patients commonly develop rapid, shallow breathing to reduce the effort required for each breath.

58. How can emphysema impair ventilation despite increased lung compliance?
Emphysema reduces elastic recoil, which can impair exhalation, promote air trapping, and reduce effective carbon dioxide elimination.

59. What is physiologic deadspace?
Physiologic deadspace is the sum of anatomic deadspace and alveolar deadspace.

60. What is alveolar deadspace?
Alveolar deadspace consists of alveoli that are ventilated but receive insufficient blood flow for effective gas exchange.

61. How can pulmonary embolism increase deadspace ventilation?
A pulmonary embolism blocks blood flow to ventilated alveoli, creating regions that receive ventilation without adequate perfusion.

62. Why does increased deadspace raise ventilatory demand?
More of each breath becomes wasted ventilation, so the patient must increase minute ventilation to maintain adequate alveolar ventilation.

63. What deadspace-to-tidal-volume ratio suggests severe ventilatory impairment?
A deadspace-to-tidal-volume ratio above approximately 0.60 to 0.70 suggests severe ventilatory impairment.

64. What is the relationship between PaCO₂ and alveolar ventilation?
PaCO₂ is inversely related to alveolar ventilation, so PaCO₂ rises when alveolar ventilation falls.

65. Why can a patient have a high minute ventilation and still be hypoventilating?
A large portion of the minute ventilation may be wasted in deadspace, leaving inadequate effective alveolar ventilation.

66. What is a common cause of chronic hypercapnic respiratory failure?
COPD is a common cause of chronic hypercapnic respiratory failure.

67. What hematologic adaptation may occur with chronic hypoxemia?
Chronic hypoxemia may stimulate erythropoietin production and lead to secondary polycythemia.

68. What is the primary purpose of noninvasive ventilation in hypercapnic respiratory failure?
The primary purpose is to improve alveolar ventilation while reducing the work placed on fatigued respiratory muscles.

69. In which acute respiratory condition is noninvasive ventilation considered standard care for appropriate patients?
Noninvasive ventilation is considered standard care for appropriate patients with COPD exacerbation accompanied by hypercapnia and respiratory acidosis.

70. What blood gas pattern commonly supports the use of NIV in a COPD exacerbation?
A PaCO₂ above 45 mm Hg with a pH below 7.35 commonly supports the use of NIV in an appropriate patient.

71. How can noninvasive ventilation improve tidal volume?
Inspiratory pressure assistance can augment the patient’s spontaneous breath and increase tidal volume.

72. How can positive airway pressure help patients with intrinsic PEEP?
Positive airway pressure can reduce the inspiratory effort needed to overcome intrinsic PEEP and initiate a breath.

73. Why may CPAP help in acute cardiogenic pulmonary edema?
CPAP can improve oxygenation, increase functional residual capacity, and reduce cardiac preload and afterload.

74. When should noninvasive ventilation not delay intubation?
NIV should not delay intubation when the patient has progressive respiratory failure, inability to protect the airway, severe instability, or worsening gas exchange despite support.

75. What is the main purpose of invasive mechanical ventilation in respiratory failure?
The main purpose is to support oxygenation and ventilation while reducing respiratory muscle workload and allowing treatment of the underlying cause.

76. What are the major goals of mechanical ventilation in respiratory failure?
The major goals are to improve oxygenation, improve alveolar ventilation, correct severe respiratory acidosis, reduce work of breathing, and rest fatigued respiratory muscles.

77. What tidal volume range is commonly used for many mechanically ventilated patients without severe acute lung injury?
A tidal volume of approximately 6 to 8 mL/kg of predicted body weight is commonly used.

78. Why is predicted body weight used to select tidal volume?
Predicted body weight better reflects lung size than actual body weight and helps reduce the risk of excessive tidal volume delivery.

79. What plateau pressure is generally targeted during lung-protective ventilation?
Plateau pressure is generally kept at or below approximately 30 cm H₂O when possible.

80. Why is a high plateau pressure concerning?
A high plateau pressure suggests excessive alveolar distending pressure and an increased risk of ventilator-induced lung injury.

81. What ventilator strategy is commonly used in ARDS?
ARDS is commonly managed with lower tidal volumes, limitation of plateau pressure, and appropriate PEEP.

82. Why is PEEP useful in ARDS?
PEEP helps maintain alveolar recruitment, reduce collapse at end expiration, decrease shunting, and improve oxygenation.

83. Why should unnecessary ventilator disconnections be avoided in severe hypoxemic respiratory failure?
Disconnection can cause loss of PEEP, alveolar derecruitment, and worsening hypoxemia.

84. How can suctioning be performed more safely in a severely hypoxemic patient?
Preoxygenation, short suction passes, and closed suction systems can help reduce procedure-related hypoxemia.

85. What is refractory hypoxemia?
Refractory hypoxemia is severe arterial hypoxemia that does not improve adequately despite high concentrations of supplemental oxygen.

86. What does severe hypoxemia despite a high FiO₂ suggest?
It suggests significant intrapulmonary shunting or severe impairment of gas exchange.

87. Why should chronic hypercapnia not always be rapidly corrected to a normal PaCO₂?
Rapid correction can leave retained bicarbonate unopposed and produce posthypercapnic metabolic alkalosis.

88. What complications can occur with posthypercapnic metabolic alkalosis?
Possible complications include hypokalemia, cardiac arrhythmias, neurologic changes, and seizures.

89. What is the usual oxygen saturation target for many patients at risk for hypercapnic respiratory failure from COPD?
An SpO₂ target of approximately 88% to 92% is commonly used in appropriate patients.

90. Why can excessive oxygen be problematic in some patients with COPD?
Excessive oxygen may worsen carbon dioxide retention and acidemia in susceptible patients.

91. What findings should be assessed after a patient is placed on mechanical ventilation?
Chest expansion, delivered and returned tidal volume, breath sounds, oxygenation, ventilation, pulmonary mechanics, hemodynamics, comfort, and patient-ventilator synchrony should be assessed.

92. What should improve before a patient is considered for liberation from mechanical ventilation?
The underlying cause of respiratory failure should improve, and the patient should have acceptable oxygenation, hemodynamic stability, adequate spontaneous breathing, and reasonable acid-base status.

93. What P/F ratio may support readiness for a spontaneous breathing trial?
A P/F ratio of approximately 150 to 200 or greater may support readiness when other criteria are also satisfied.

94. What PEEP level is commonly acceptable before attempting a spontaneous breathing trial?
A PEEP level of approximately 5 to 8 cm H₂O or less is commonly acceptable.

95. What FiO₂ level is commonly acceptable before attempting a spontaneous breathing trial?
An FiO₂ of approximately 0.40 to 0.50 or less is commonly acceptable.

96. What is the purpose of a spontaneous breathing trial?
A spontaneous breathing trial evaluates whether a patient can maintain adequate ventilation and oxygenation with minimal or no ventilatory assistance.

97. What are common signs of spontaneous breathing trial failure?
Tachypnea, worsening gas exchange, increased work of breathing, diaphoresis, anxiety, hemodynamic instability, altered mental status, and thoracoabdominal paradox are common signs.

98. What should be done if a patient fails a spontaneous breathing trial?
Adequate ventilatory support should be restored and the cause of failure should be identified and corrected before another trial.

99. Why can excessive carbohydrate intake be problematic in patients with respiratory failure?
Carbohydrate metabolism produces relatively large amounts of carbon dioxide, which can increase the ventilatory burden in patients who already have difficulty eliminating CO₂.

100. What is the overall approach to managing respiratory failure?
Management involves identifying whether oxygenation, ventilation, or both are impaired, determining the underlying cause, correcting gas exchange abnormalities, reducing respiratory workload, and providing appropriate respiratory support.

Final Thoughts

Respiratory failure occurs when the respiratory system can no longer maintain adequate oxygenation, ventilation, or both. Recognizing whether the dominant problem involves hypoxemia, hypercapnia, or a combination of the two helps guide treatment.

Assessment should include arterial blood gases, oxygen requirements, breathing pattern, respiratory muscle strength, mental status, pulmonary mechanics, and the patient’s clinical trajectory. Oxygen therapy, CPAP, noninvasive ventilation, and invasive mechanical ventilation may all be appropriate depending on severity.

The key is to identify deterioration early, treat the underlying cause, reduce excessive respiratory workload, and provide sufficient support before complete cardiopulmonary failure develops.